Entry into a Material Definitive Agreement

Business Context and Reporting Period

This Form 8-K was filed by Ekso Bionics Holdings, Inc. on August 17, 2023. The report details a material definitive agreement entered into on the same date between the Company, its wholly-owned subsidiary Ekso Bionics, Inc., and Pacific Western Bank.

Key Financial Metrics

The filing does not provide specific revenue, profit, cash flow, margin, or liquidity figures. The primary financial disclosure relates to the modification of an existing Term Loan:

  • Interest Rate: Variable annual rate equal to the greater of the Lender's "prime rate" or 4.50%.
  • Maturity Date: Extended to August 13, 2026.
  • Accounting Requirement: Borrower must maintain all depository, operating, and investment accounts with the Lender.

Material Changes

The Company executed the Fifth Amendment to its Loan and Security Agreement originally dated August 13, 2020. The material changes include:

  • Adjustment of the interest rate floor to 4.50%.
  • Extension of the loan maturity by approximately two years.
  • Implementation of a requirement to consolidate banking relationships with Pacific Western Bank.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond the obligations created by the amended loan agreement. The document notes that the summary is qualified by the full text of the Amendment filed as Exhibit 10.1.

Investor Verification Checklist

  • Verify the current outstanding principal balance of the Term Loan to assess the impact of the new interest rate floor.
  • Review the full text of the Fifth Amendment (Exhibit 10.1) for any additional covenants or default provisions not summarized in the 8-K.
  • Confirm the Company's current cash position to ensure compliance with the new requirement to maintain all accounts with Pacific Western Bank.
  • Check subsequent filings for any further amendments or financial updates regarding the loan terms.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.